MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinsonism"

  • 2018 International Congress

    Validation of a One-Page Impulse Control Disorder Questionnaire in a Parkinson’s Disease Clinic

    L. Williams, B. Magennis, N. Feerick, T. Lynch (Dublin, Ireland)

    Objective: We seek to report data on ICD symptoms collected on 120 patients with Parkinsonism attending specialist movement disorder outpatient clinics using a newly devised,…
  • 2018 International Congress

    Background: Transcranial magnetic stimulation (rTMS) may influence the progression of PD

    J. Málly (Sopron, Hungary)

    Objective: We hypothesized that the regularly repeated rTMS would decrease the development of PD and that there might be a synergistic effect with transcranial direct…
  • 2018 International Congress

    Parkinsonism & Cognitive Dysfunction Severity Correlation in NPH with a Suggested Novel Phenotypic Subclassifcation of NPH

    A. Acharya, A. Biswas, S. Das (Kolkata, India)

    Objective: In this study, we have tried to find any correlation between severity of cognitive dysfunction and parkinsonism in NPH patients & to look for…
  • 2018 International Congress

    Familial SCA2-parkinsonism presented as intractable oromandibular dystonia

    K. Woo, B. Jeon, J. Lee (Seoul, Republic of Korea)

    Objective: We report a patient of spinocerebellar ataxia type 2(SCA2)-parkinsonism family who developed oromandibular dystonia as the chief presentation. Background: We previously described a Korean…
  • 2018 International Congress

    Dual Competition between the Basal Ganglia and the Cortex: 1 from Action-Outcome to Stimulus-Response

    T. Boraud (Bordeaux, France)

    Objective: We propose a model of the interaction between the cortex, the basal ganglia and the thalamus based on a dual competition during instrumental conditioning.…
  • 2018 International Congress

    Gastric Retention of the Accordion Pill™: Results From MRI Studies With Parkinson’s Disease Patients and Healthy Volunteers

    N. Navon, R. Gendreau, J. Meckler (Jerusalem, Israel)

    Objective: To determine gastric retention (GR) of the Accordion Pill™ (AP) in patients with Parkinson’s disease (PD) and healthy volunteers. Background: While carbidopa/levodopa (CD/LD) is…
  • 2018 International Congress

    Effects of High-frequency Repetitive Transcranial Magnetic Stimulation (HF-rTMS) Combined with Task Specific Training in Individuals with Parkinson’s Disease

    J. Thanakamchokchai, J. Tretriluxana, B. Fisher, N. Pakaprot, A. PisarnPong (Nakhon Pathom, Thailand)

    Objective: To examine the effects of HF-rTMS with reach-to-grasp (RTG) training focusing on the movement amplitude Background: Previous studies applied the HF-rTMS over primary motor…
  • 2018 International Congress

    After Deep Brain Stimulation Surgery for Parkinson’s Disease risk Factors for Postoperative Delirium

    F. Rakhimov, G. Rakhimbaeva (Tashkent, Uzbekistan)

    Objective: The aim of this study was to investigate the incidence of and risk factors for postoperative delirium (POD) after deep brain stimulation (DBS) surgery…
  • 2018 International Congress

    Levodopa Effect on Dual-Tasking in Freezing of Gait in Parkinson’s Disease

    E. Bayram, J. Longhurst, S. Banks, Z. Mari, B. Bluett (Las Vegas, NV, USA)

    Objective: To assess the effect of levodopa on dual-tasking in situations triggering freezing of gait (FOG) in Parkinson’s disease (PD). Background: The frequency and severity…
  • 2018 International Congress

    Efficacy and security starting safinamide treatment with 100 mg/day in PD

    N. Foncea (Galdakao, Spain)

    Objective: Evaluating the efficacy and security starting safinamide treatment with 100 mg/day in PD Background: Dopaminergic treatment has been useful in PD. Other neurotransmission mechanisms…
  • « Previous Page
  • 1
  • …
  • 217
  • 218
  • 219
  • 220
  • 221
  • …
  • 405
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley